Volume | 112 |
|
|||||
News | - | ||||||
Day High | 16.99 | Low High |
|||||
Day Low | 16.9748 |
Company Name | Etf Ticker Symbol | Market | Type |
---|---|---|---|
WisdomTree BioRevolution Fund | WDNA | AMEX | Exchange Traded Fund |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
16.9748 | 16.9748 | 16.99 | 17.0446 | 16.9748 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
12 | 112 | 16.99 | 1,903 | - | 15.94 - 20.29 |
Last Trade Time | Type | Quantity | Etf Price | Currency |
---|---|---|---|---|
20:00:03 | 100 | 17.0446 | USD |
WisdomTree BioRevolution Fund Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
2.73M | 160.00k | 160.00k | - | - | - | 17.80 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | 0.38% | 12/23/22 | - | - |
News WisdomTree BioRevolution
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
WDNA Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 17.2078 | 18.00 | 16.95 | 17.63 | 516 | -0.1632 | -0.95% |
1 Month | 16.8344 | 18.00 | 16.8344 | 17.52 | 371 | 0.2102 | 1.25% |
3 Months | 17.37 | 18.00 | 16.41 | 17.23 | 240 | -0.3254 | -1.87% |
6 Months | 18.2615 | 18.8066 | 16.41 | 17.75 | 472 | -1.22 | -6.66% |
1 Year | 17.3647 | 20.29 | 15.94 | 17.99 | 927 | -0.3201 | -1.84% |
3 Years | 24.90 | 28.18 | 15.94 | 21.85 | 1,671 | -7.86 | -31.55% |
5 Years | 24.90 | 28.18 | 15.94 | 21.85 | 1,671 | -7.86 | -31.55% |
The WisdomTree BioRevolution Fund (Fund) seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution Index (Index). The Fund employs a passive management or indexing investment approach designed to track the performance of the Index. The Fund generally uses a representative sampling strategy to achieve its investment objective, meaning it generally will invest in a sample of the securities in the Index whose risk, return and other characteristics resemble the risk, return and other characteristics of the Index as a whole. The Index is designed to provide exposure to equity securities of exchange-listed companies globally that will be significantly transformed by advancements in genetics and biotechnology. |